305 related articles for article (PubMed ID: 31089071)
21. [Fertility preservation in women of the childbearing age: Indications and strategies].
Bénard J; Calvo J; Comtet M; Benoit A; Sifer C; Grynberg M
J Gynecol Obstet Biol Reprod (Paris); 2016 May; 45(5):424-44. PubMed ID: 27021926
[TBL] [Abstract][Full Text] [Related]
22. Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity.
Cho HW; Lee S; Min KJ; Hong JH; Song JY; Lee JK; Lee NW; Kim T
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096794
[TBL] [Abstract][Full Text] [Related]
23. Ovarian protection and fertility preservation in women with cancer: A French national registry analysis between 2005 and 2014.
Phelippeau J; Cazalis CG; Koskas M
J Gynecol Obstet Hum Reprod; 2019 Nov; 48(9):705-710. PubMed ID: 31276847
[TBL] [Abstract][Full Text] [Related]
24. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
Sermondade N; Sonigo C; Sifer C; Valtat S; Ziol M; Eustache F; Grynberg M
Fertil Steril; 2019 Feb; 111(2):357-362. PubMed ID: 30527837
[TBL] [Abstract][Full Text] [Related]
25. Timing of fertility preservation procedures in a cohort of female patients with cancer.
Jenninga E; Louwe LA; Peters AA; Nortier JW; Hilders CG
Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):170-3. PubMed ID: 22137982
[TBL] [Abstract][Full Text] [Related]
26. Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for women.
Kim SY; Kim SK; Lee JR; Woodruff TK
J Gynecol Oncol; 2016 Mar; 27(2):e22. PubMed ID: 26768785
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of the ovaries in women with breast cancer undergoing fertility preservation: Alternative versus standard stimulation protocols; the study protocol of the STIM-trial.
Dahhan T; Balkenende EME; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; van Golde RJT; Schipper I; Louwé LA; Cantineau AEP; Smeenk JMJ; de Bruin JP; Reddy N; Kopeika Y; van der Veen F; van Wely M; Linn SC; Goddijn M
Contemp Clin Trials; 2017 Oct; 61():96-100. PubMed ID: 28710053
[TBL] [Abstract][Full Text] [Related]
28. Outcome of immature oocytes collection of 119 cancer patients during ovarian tissue harvesting for fertility preservation.
Kedem A; Yerushalmi GM; Brengauz M; Raanani H; Orvieto R; Hourvitz A; Meirow D
J Assist Reprod Genet; 2018 May; 35(5):851-856. PubMed ID: 29574609
[TBL] [Abstract][Full Text] [Related]
29. Fertility preservation in ovarian cancer patients.
Santos ML; Pais AS; Almeida Santos T
Gynecol Endocrinol; 2021 Jun; 37(6):483-489. PubMed ID: 33501866
[TBL] [Abstract][Full Text] [Related]
30. [Fertility preserving methods in women with breast cancer before gonadotoxic therapy].
Halászová N; Crha I; Huser M; Weinberger V; Žáková J; Ješeta M; Lousová E; Filipinská E; Ventruba P
Ceska Gynekol; 2017; 82(4):287-292. PubMed ID: 28925272
[TBL] [Abstract][Full Text] [Related]
31. Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
Quinn MM; Cakmak H; Letourneau JM; Cedars MI; Rosen MP
Hum Reprod; 2017 Mar; 32(3):568-574. PubMed ID: 28122888
[TBL] [Abstract][Full Text] [Related]
32. [Fertility preservation in breast cancer patients: the state of art in 2014?].
Comtet M; Sonigo C; Valdelièvre C; Sermondade N; Sifer C; Grynberg M
Bull Cancer; 2015 May; 102(5):443-53. PubMed ID: 25739327
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer and fertility: an update.
Ronn R; Holzer H
Curr Opin Support Palliat Care; 2015 Sep; 9(3):285-93. PubMed ID: 26262832
[TBL] [Abstract][Full Text] [Related]
34. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
[TBL] [Abstract][Full Text] [Related]
35. [Fertility preservation in oncology].
Chaput L; Grémeau AS; Vorilhon S; Pons H; Chabrot C; Grèze V; Pouly JL; Brugnon F
Bull Cancer; 2018 Jan; 105(1):99-110. PubMed ID: 29221621
[TBL] [Abstract][Full Text] [Related]
36. Fertility-preservation counselling and treatment for medical reasons: data from a multinational network of over 5000 women.
von Wolff M; Dittrich R; Liebenthron J; Nawroth F; Schüring AN; Bruckner T; Germeyer A
Reprod Biomed Online; 2015 Nov; 31(5):605-12. PubMed ID: 26380870
[TBL] [Abstract][Full Text] [Related]
37. Fertility preservation and preimplantation genetic assessment for women with breast cancer.
Sciorio R; Anderson RA
Cryobiology; 2020 Feb; 92():1-8. PubMed ID: 31863734
[TBL] [Abstract][Full Text] [Related]
38. Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study.
Lambertini M; Fontana V; Massarotti C; Poggio F; Dellepiane C; Iacono G; Abate A; Miglietta L; Ferreccio C; Pescio MC; Conte B; Blondeaux E; Bighin C; D'Alonzo A; Vaglica M; Zanardi E; Boccardo F; Ballestrero A; Anserini P; Del Mastro L
Breast; 2018 Oct; 41():51-56. PubMed ID: 30007268
[TBL] [Abstract][Full Text] [Related]
39. Vitrification of in vitro matured oocytes collected from surplus ovarian medulla tissue resulting from fertility preservation of ovarian cortex tissue.
Yin H; Jiang H; Kristensen SG; Andersen CY
J Assist Reprod Genet; 2016 Jun; 33(6):741-6. PubMed ID: 26984232
[TBL] [Abstract][Full Text] [Related]
40. Strategies for fertility preservation in young early breast cancer patients.
Tomasi-Cont N; Lambertini M; Hulsbosch S; Peccatori AF; Amant F
Breast; 2014 Oct; 23(5):503-10. PubMed ID: 24934638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
